Extension of useful reagent shelf life beyond manufacturers' recommendations

Archives of Pathology and Laboratory Medicine

Volumn 122, Issue 12, 1998, Pages 1051-1052

  Tubbs, Raymond R ^a   Nagle, Raymond ^b   Leslie, Kevin ^c   Pettigrew, Norman M ^d   Said, Jonathan W ^e   Corwin, David J ^f   Rickert, Robert R ^g   Roche, Patrick C ^h  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c MAYO CLINIC   (United States)

^d HEALTH SCIENCES CENTRE   (Canada)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Washington Pathology Consultants I   (United States)

^g SAINT BARNABAS MEDICAL CENTER   (United States)

^h MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HMB 45; PROTEIN S 100; REAGENT;

ANGIOMYOLIPOMA; ARTICLE; DRUG MANUFACTURE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY DIAGNOSIS; LARGE CELL LYMPHOMA; MELANOMA; SHELF LIFE;

ANTIBODIES; HUMANS; IMMUNOHISTOCHEMISTRY; INDICATORS AND REAGENTS; NEOPLASMS; QUALITY CONTROL; TUMOR MARKERS, BIOLOGICAL;

EID: 0032419299     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Howanitz PJ, Howanitz JH. Quality assurance. In: Rose NR, de Macario EC, Folds JD, Lane HC, Nakamura RM, eds. Manual of Clinical Laboratory Immunology. 5th ed. Washington, DC: American Society of Microbiology; 1997:1185.
2. Department of Health and Human Services Health Care Financing Administration Agency. Health Care Financing Administration (HCFA), HHS, 42 CFR Parts 493 and 498 Clinical Laboratories Improvement Act Program; Granting and Withdrawal of Deeming Authority to Private Nonprofit Accreditation Organizations and of CLIA Exempt Under State Laboratory Programs, (HSQ-181-F) RIN 0938-AE62, 57 FR 33992, July 31, 1992.